Charles A Peloquin Selected Research

Charles A Peloquin Research Topics

Disease

81	Tuberculosis (Tuberculoses) 06/2022 - 01/2002
27	Infections 01/2022 - 06/2004
19	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 06/2022 - 08/2006
17	Pulmonary Tuberculosis 12/2021 - 01/2002
14	HIV Infections (HIV Infection) 01/2021 - 05/2005
9	Body Weight (Weight, Body) 01/2020 - 06/2002
7	Critical Illness (Critically Ill) 01/2022 - 08/2003
5	Meningeal Tuberculosis (Tuberculous Meningitis) 09/2022 - 04/2015
5	Invasive Fungal Infections 01/2017 - 01/2013
3	Inflammation (Inflammations) 01/2022 - 11/2008
3	Coinfection 01/2021 - 01/2019
3	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2020
3	Latent Tuberculosis 10/2016 - 04/2014
3	Communicable Diseases (Infectious Diseases) 10/2016 - 01/2002
3	Mycoses (Diseases, Fungus) 01/2016 - 08/2008
2	Seizures (Absence Seizure) 01/2022 - 06/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 09/2021
2	Extensively Drug-Resistant Tuberculosis 01/2021 - 06/2014
2	Liver Diseases (Liver Disease) 07/2014 - 10/2006
2	Granuloma 08/2013 - 08/2012
2	Lung Diseases (Lung Disease) 09/2012 - 08/2008
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Ventilator-Associated Pneumonia 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Gram-Negative Bacterial Infections 09/2021
1	Meningitis 06/2021
1	Sepsis (Septicemia) 06/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Cross Infection (Nosocomial Infection) 10/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2018
1	Immune Reconstitution Inflammatory Syndrome 02/2017

Drug/Important Bio-Agent (IBA)

56	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
34	Rifampin (Rifampicin)FDA LinkGeneric 06/2022 - 09/2002
25	Isoniazid (Ftivazide)FDA LinkGeneric 01/2018 - 09/2002
19	Pyrazinamide FDA LinkGeneric 06/2022 - 06/2002
15	Linezolid (Zyvox)FDA Link 09/2022 - 08/2003
15	rifapentine (Priftin)FDA Link 10/2017 - 05/2003
10	Moxifloxacin (Avelox)FDA Link 03/2019 - 12/2005
9	Levofloxacin (Levaquin)FDA Link 01/2019 - 03/2008
9	RifamycinsIBA 10/2017 - 08/2003
7	Ethambutol (Myambutol)FDA LinkGeneric 01/2018 - 12/2005
6	FluoroquinolonesIBA 06/2022 - 04/2011
6	AerosolsIBA 08/2013 - 04/2009
6	Rifabutin (Ansamycin)FDA Link 11/2009 - 08/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2009
5	Voriconazole (Vfend)FDA LinkGeneric 01/2017 - 08/2008
4	Clofazimine (Lamprene)FDA Link 06/2022 - 01/2018
4	pretomanidIBA 12/2011 - 08/2006
3	Cefepime (Maxipime)FDA LinkGeneric 01/2022 - 01/2020
3	bedaquiline (R207910)IBA 12/2021 - 12/2011
3	posizolidIBA 01/2018 - 11/2016
3	Drug CombinationsIBA 08/2013 - 03/2011
3	Vancomycin FDA LinkGeneric 10/2007 - 10/2003
2	Cycloserine (Seromycin)FDA Link 09/2022 - 01/2019
2	EnzymesIBA 01/2022 - 07/2014
2	beta-LactamsIBA 01/2022 - 09/2021
2	OPC-67683IBA 12/2021 - 10/2019
2	AcidsIBA 01/2021 - 01/2017
2	Nevirapine (Viramune)FDA Link 01/2021 - 10/2019
2	Lamivudine (Epivir)FDA Link 01/2021 - 01/2020
2	efavirenz (Sustiva)FDA Link 01/2019 - 11/2005
2	Cytochrome P-450 CYP2C19IBA 01/2017 - 07/2014
2	Amikacin (A.M.K)FDA LinkGeneric 01/2017 - 06/2004
2	Biomarkers (Surrogate Marker)IBA 10/2016 - 10/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2014 - 11/2005
2	posaconazole FDA Link 01/2013 - 09/2012
2	Dihydrotachysterol (AT 10)IBA 09/2012 - 07/2012
2	Streptomycin (Streptomycin Sulfate)FDA Link 10/2010 - 06/2004
2	PowdersIBA 08/2009 - 04/2009
1	Vigabatrin FDA Link 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Antitubercular AgentsIBA 12/2021
1	beta Lactam AntibioticsIBA 09/2021
1	Reverse Transcriptase InhibitorsIBA 01/2021
1	NucleosidesIBA 01/2021
1	abacavir (Ziagen)FDA Link 01/2021
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2021
1	Antiviral Agents (Antivirals)IBA 10/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	Isonicotinic Acids (Isonicotinic Acid)IBA 01/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020
1	Losartan (Cozaar)FDA LinkGeneric 01/2020
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2020
1	Ethionamide (Trecator-SC)FDA Link 01/2020
1	Tenofovir (Viread)FDA Link 01/2020
1	TabletsIBA 01/2020
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 10/2019
1	Verapamil (Calan)FDA LinkGeneric 01/2018
1	OxindolesIBA 10/2017
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2017

Therapy/Procedure

37	Therapeutics 01/2022 - 05/2003
6	Duration of Therapy 01/2021 - 08/2006
4	Continuous Renal Replacement Therapy 01/2022 - 08/2003
3	Drug Therapy (Chemotherapy) 11/2016 - 01/2002
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Art Therapy 10/2019